✨
AI Summary
- Dr. Edward Kaye discusses Aurora Therapeutics' strategy for scaling CRISPR gene editing.
- Platform approach targets phenylketonuria (PKU) using shared components.
- Customizing guide RNAs for specific mutations to treat rare diseases.